Showing results (701-710 of 744) with videos related to
Sort By:
Pageof 75
Cancer Research|September 16, 2010
Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cellsJoyce E Ohm, Prashant Mali, Leander Van Neste, et al.Archives of Pathology & Laboratory Medicine|August 6, 2014
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer FoundationMahul B Amin, Daniel W Lin, John L Gore, et al.Cancer Medicine|May 22, 2014
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladderElizabeth A Guancial, Lillian Werner, Joaquim Bellmunt, et al.The American Journal of Pathology|September 6, 2011
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypesChristopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, et al.The American Journal of Pathology|February 13, 2002
Evaluation of non-formalin tissue fixation for molecular profiling studiesJohn W Gillespie, Carolyn J M Best, Verena E Bichsel, et al.Journal of the National Cancer Institute|March 5, 2020
Risk Stratification of Prostate Cancer Through Quantitative Assessment of PTEN Loss (qPTEN)Tamara Jamaspishvili, Palak G Patel, Yi Niu, et al.The American Journal of Surgical Pathology|June 23, 2025
International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The ProstateKenneth A Iczkowski, Angelo M De Marzo, Neeraj Agarwal, et al.Cancer Research|April 29, 2025
Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Anti-tumor Immunity and Improve Immunotherapy EfficacyBrian J Laight, Danielle Harper, Natasha Dmytryk, et al.The American Journal of Surgical Pathology|October 5, 2018
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the KidneyLisha Wang, Yuping Zhang, Ying-Bei Chen, et al.The Journal of Pathology|October 18, 2023
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancerRadhika A Patel, Erolcan Sayar, Ilsa Coleman, et al.Pageof 75